Synthesis of 1-(2-{2-[4-Fluoro-2-(4-[18F]fluorobenzoyl)phenyl]vinyloxy}ethyl)nipecotic Acid for PET imaging of GAT-1

被引：0

作者：

Sowa, Alexandra ^{[1
]}

Brooks, Allen ^{[1
]}

Scott, Peter ^{[1
]}

Kilbourn, Michael ^{[1
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

1047

引用

页数：2

共 50 条

[1] Synthesis of a Dopamine Uptake Inhibitor for PET Studies: 1-[1-(2- Benzo(b)thiophenyl)Cyclohexyl]-4-(2-[18F$R B@ Fluoroethyl)Piperazine
Loustau-Then, I.
Ponchant, M.
Kamenka, J. M.
Crouzel, C.
Journal of Labelled Compounds and Radiopharmaceuticals, 38 (03):
[2] Synthesis of 1-[2-[18F]fluoro-1-(hydroxymethyl)-ethoxy] methyl-2-nitroimidazole ([18F]FENI), a potential agent for imaging hypoxic tissues by PET
Wada, H
Iwata, R
Ido, T
Takai, Y
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (08): : 785 - 793
[3] Synthesis of 1-[2-[18F]fluoro-1-(hydroxymethyl)-ethoxy]methyl-2-nitroimidazole ([18F]FENI), a potential agent for imaging hypoxie tissues by PET
Iwata, R. (ren.iwata@qse.tohoku.ac.jp), 2000, John Wiley and Sons Ltd (43)
[4] Synthesis of 1-[2-[18F]Fluoro-1-(hydroxymethyl)-ethoxy]methyl-2-nitroimidazole ([18F]FENI), a potential agent for imaging hypoxic tissues by PET
Wada, Hiroaki
Iwata, Ren
Ido, Tatsuo
Takai, Yoshihiro
Journal of Labelled Compounds and Radiopharmaceuticals, 2000, 43 (08) : 785 - 793
[5] Improved Microfluidic Synthesis of 1-(2-[18F]fluoroethoxy)-4-[2-{4-(methylsulfonyl) phenyl}cyclopent-1-enyl]benzene, a potential COX-2 inhibitor to characterize solid tumors.
Akula, Murthy
Blevins, David
Kabalka, George
Osborne, Dustin
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S580 - S580
[6] Synthesis of a dopamine uptake inhibitor for pet studies: 1-[1-(2-BENZO(b)thiophenyl)cyclohexyl] -4-(2-[18F]fluoroethyl) piperazine
Serv. Hosp. Frederic-Joliot, D.R.M., C.E.A., 4 Pl. du Gén. Leclerc, 91406 Orsay, France
不详
J. Label. Compd. Radiopharm., 3 (298-308):
[7] 2-[1-({2-[1-(2-Hydroxy-5-{[methyl(phenyl)amino]methyl}phenyl)ethylideneamino]ethyl}imino)ethyl]-4-{[methyl(phenyl)amino]methyl}phenol
Ourari, Ali
Ouennoughi, Yasmina
Bouacida, Sofiane
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1562 - +
[8] Methyl 3-(dimethylamino)-2-[2-(1-{3-[4-(methylsulfanyl)phenyl]-1,2,4-oxadiazol-5-yl}-2-(dimethylamino)vinyloxy)phenyl]acrylate
Wang, HB
Chen, JH
Pu, YQ
Wang, JT
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O58 - O59
[9] 2-((4-((E)-1-(Hydroxyimino)ethyl)phenyl)amino)-2-oxoethyl Cinnamate
Tsopka, Ioanna-Chrysoula
Hadjipavlou-Litina, Dimitra
MOLBANK, 2021, 2021 (03)
[10] 1-{2-( 4-Chlorobenzyloxy)-2-[4-(morpholin- 4- yl) phenyl] ethyl}-1H-benzimidazole propan-2-ol monosolvate
Guven, Ozden Ozel
Capanlar, Seval
Adler, Philip D. F.
Coles, Simon J.
Hokelek, Tuncer
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1437 - +

← 1 2 3 4 5 →